In what’s described as a revolutionary advance in medicine, the University of Pittsburgh in collaboration with UPMC will receive a $4.2 million grant through the National Institutes of Health to participate in the Precision Medicine Initiative that President Barack Obama announced in his 2015 State of the Union address.

Over five years, Pitt could receive more than $46 million in program funding, based on the progress it makes and availability of NIH funds.

The NIH says traditional medicine takes a “one size fits all” approach geared toward treating the average patient. But the new precision-medicine approach takes into account individual differences in genes, microbiome composition, health history, lifestyle and diet to determine ideal treatment.

In a published statement, NIH Director Francis S. Collins said the people to be enrolled in the program “will help us answer important health questions such as why some people with elevated genetic and environmental risk factors for disease still manage to maintain good health and how people suffering from a chronic illness can maintain the highest ... quality of life.”

Advertise with us

“The more we understand about individual differences, the better able we will be to effectively prevent and treat illness,” he said.

In an initial step, Pitt and UPMC will join a support network of health care provider organizations including regional medical centers nationwide that collectively plan to enroll 1 million participants by 2020, with potentially many millions more over time. The result will be the largest research cohort ever collected to study diseases and treatments.

Pitt’s goal is to recruit 10,000 people in Western Pennsylvania and surrounding states in the first year and 175,000 people over five years.

Arthur S. Levine, Pitt’s senior vice chancellor for the health sciences and dean of the University of Pittsburgh School of Medicine, characterized the Precision Medicine Initiative as one of NIH’s “most ambitious research efforts since the Human Genome Project.”

“We are on the cusp of a new era in medicine in which we can apply knowledge in genetics, genomics, combined with lifestyle and environmental data and other disciplines to improve disease prevention strategies and tailor treatment options for everyone,” he said in a statement.

Advertise with us

With the grant, Pitt’s Clinical and Translational Science Institute will launch Precision Approach to healthCARE (PA CARES) at 11 enrollment sites across Western Pennsylvania and neighboring states. Initially, the goal is to collect lifestyle information and medical histories take blood and urine samples to document genetic and medical details about each participant.

“That will contribute nationally to a revolution in how research and clinical care is done for us, our children and grandchildren. It will provide the basis for an individual approach to the diagnoses, prevention and treatment of disease,” said Steven E. Reis, associate vice chancellor for clinical research and director of the science Institute. “This comprehensive massive collection of patient information, combined with our advanced analytics approach, will eventually enable us to treat each patient in a personalized way to produce the best possible results.”

Cancer will be one focus, where one’s genetic makeup and details about tumor or cancer cells can lead to tailored treatments. Molecular testing as a standard part of patient care would allow physicians to select treatments that improve chances of survival while reducing exposure to adverse effects.

The White House announcement on the initiative described its aims: “Success will require that health data is portable, that it can be easily shared between providers, researchers and most importantly, patients and research participants.”

People can enroll in the program through Pitt’s registry at www.researchregistry.pitt.edu.

David Templeton: dtempleton@post-gazette.com.